Abstract
Simpson-Golabi-Behmel syndrome (SGBS) is one of the overgrowth syndromes. Microdeletions of the glypican-3 (GPC3) gene were described by Pilia et al. (1996). Glypican-3 encodes a putative extracellular proteoglycan which is expressed in embryonic mesodermal tissues and plays an important role in embryonal growth. We report a Japanese patient with SGBS who had a single base deletion in the exon 7 of the GPC3 gene. This is the first report of a single base deletion of the GPC3 gene.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: January 7, 1999 / Accepted: April 20, 1999
Rights and permissions
About this article
Cite this article
Okamoto, N., Yagi, M., Imura, K. et al. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome. J Hum Genet 44, 327–329 (1999). https://doi.org/10.1007/s100380050170
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380050170
This article is cited by
-
Loss-of-function mutations and global rearrangements in GPC3 in patients with Simpson–Golabi–Behmel syndrome
Human Genome Variation (2016)
-
Clinical and oral findings of a patient with Simpson–Golabi–Behmel syndrome
European Archives of Paediatric Dentistry (2015)
-
A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values
BMC Cancer (2013)
-
The Human Obesity Gene Map: The 2004 Update
Obesity Research (2005)
-
The Human Obesity Gene Map: The 2002 Update
Obesity Research (2003)